Bcl2L12 is an inhibitor of the activation of postmitochondrial effector caspases that is overexpressed in glioblastoma, playing an anti-apoptotic role; it features a dominion similar to BH3 in its structure, which interacts with Bcl-xL and Bcl2. This evidence concerns the gene BCL2L1 and glioblastoma.